DD135900A5 - Verfahren zur herstellung von somatostatinanaloga und zwischenprodukten hierfuer - Google Patents

Verfahren zur herstellung von somatostatinanaloga und zwischenprodukten hierfuer

Info

Publication number
DD135900A5
DD135900A5 DD78204957A DD20495778A DD135900A5 DD 135900 A5 DD135900 A5 DD 135900A5 DD 78204957 A DD78204957 A DD 78204957A DD 20495778 A DD20495778 A DD 20495778A DD 135900 A5 DD135900 A5 DD 135900A5
Authority
DD
German Democratic Republic
Prior art keywords
somatostatinanaloga
herefuer
production
intermediate products
products
Prior art date
Application number
DD78204957A
Other languages
English (en)
Inventor
James E Shields
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD135900A5 publication Critical patent/DD135900A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin
DD78204957A 1977-04-21 1978-04-21 Verfahren zur herstellung von somatostatinanaloga und zwischenprodukten hierfuer DD135900A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/789,472 US4100117A (en) 1977-04-21 1977-04-21 Somatostatin analogs and intermediates thereto

Publications (1)

Publication Number Publication Date
DD135900A5 true DD135900A5 (de) 1979-06-06

Family

ID=25147748

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78204957A DD135900A5 (de) 1977-04-21 1978-04-21 Verfahren zur herstellung von somatostatinanaloga und zwischenprodukten hierfuer

Country Status (31)

Country Link
US (1) US4100117A (de)
JP (1) JPS53132588A (de)
AR (1) AR221699A1 (de)
AT (1) AT361142B (de)
AU (1) AU519275B2 (de)
BE (1) BE866117A (de)
BG (1) BG28703A3 (de)
CA (2) CA1102315A (de)
CH (1) CH634039A5 (de)
CS (1) CS202096B2 (de)
DD (1) DD135900A5 (de)
DE (1) DE2816854A1 (de)
DK (1) DK174278A (de)
ES (2) ES469005A1 (de)
FI (1) FI64576C (de)
FR (1) FR2387941A1 (de)
GB (1) GB1596328A (de)
GR (1) GR68945B (de)
HU (1) HU177435B (de)
IE (1) IE46868B1 (de)
IL (1) IL54533A (de)
IT (1) IT1094462B (de)
NL (1) NL7804218A (de)
NZ (1) NZ187009A (de)
PL (2) PL114533B1 (de)
PT (1) PT67913B (de)
RO (2) RO81079A (de)
SE (1) SE7804397L (de)
SU (2) SU730295A3 (de)
YU (1) YU91578A (de)
ZA (1) ZA782247B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202802A (en) * 1978-10-02 1980-05-13 Eli Lilly And Company Peptides related to somatostatin
US4199501A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4199500A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
SE8702550D0 (sv) * 1987-06-18 1987-06-18 Anders Grubb Cysteinproteashemmare
NO302481B1 (no) 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
ES2110573T3 (es) 1992-08-07 1998-02-16 Takeda Chemical Industries Ltd Produccion de microcapsulas de farmacos solubles en agua.
CA2143044C (en) * 1994-02-21 2005-04-12 Yasutaka Igari Matrix for sustained-release preparation
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
EP0813887A3 (de) * 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. Iontophoretische Vorrichtung
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
EP2062593A3 (de) 2000-12-01 2011-08-17 Takeda Pharmaceutical Company Limited Verfahren zur Herstellung einer Zubereitung mit bioaktiven Peptiden
US6867183B2 (en) * 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6713452B2 (en) * 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7601688B2 (en) * 2002-06-13 2009-10-13 Biocon Limited Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
CA2910494C (en) 2004-07-19 2018-10-23 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
MX2010003979A (es) 2007-10-16 2010-06-02 Biocon Ltd Composicion farmaceutica oralmente administrable y proceso para su preparacion.
EP2873422A4 (de) 2012-07-10 2015-12-30 Takeda Pharmaceutical Pharmazeutische zubereitung zur injektion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2608336A1 (de) * 1975-03-11 1976-09-30 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides

Also Published As

Publication number Publication date
BE866117A (fr) 1978-10-19
IL54533A0 (en) 1978-07-31
IL54533A (en) 1982-11-30
ES469005A1 (es) 1979-09-01
FI64576C (fi) 1983-12-12
US4100117A (en) 1978-07-11
GR68945B (de) 1982-03-29
BG28703A3 (en) 1980-06-16
PT67913A (en) 1978-05-01
AU519275B2 (en) 1981-11-19
SU730295A3 (ru) 1980-04-25
NL7804218A (nl) 1978-10-24
RO81079A (ro) 1983-06-01
RO76054A (ro) 1981-08-17
ES476901A1 (es) 1979-10-16
PL114533B1 (en) 1981-02-28
CA1113928A (en) 1981-12-08
AU3525378A (en) 1979-10-25
IE46868B1 (en) 1983-10-19
ATA282878A (de) 1980-07-15
CH634039A5 (de) 1983-01-14
SU904519A3 (ru) 1982-02-07
PL115827B1 (en) 1981-05-30
JPS53132588A (en) 1978-11-18
DK174278A (da) 1978-10-22
FI781184A (fi) 1978-10-22
GB1596328A (en) 1981-08-26
HU177435B (en) 1981-10-28
PT67913B (en) 1979-11-14
CS202096B2 (en) 1980-12-31
CA1102315A (en) 1981-06-02
ZA782247B (en) 1979-12-27
NZ187009A (en) 1981-04-24
IT7822552A0 (it) 1978-04-20
FR2387941A1 (fr) 1978-11-17
SE7804397L (sv) 1978-10-22
DE2816854A1 (de) 1978-11-02
AT361142B (de) 1981-02-25
IE780765L (en) 1978-10-21
RO81079B (ro) 1983-05-30
AR221699A1 (es) 1981-03-13
YU91578A (en) 1983-01-21
FI64576B (fi) 1983-08-31
PL206280A1 (de) 1980-01-02
FR2387941B1 (de) 1983-06-10
IT1094462B (it) 1985-08-02

Similar Documents

Publication Publication Date Title
DD135900A5 (de) Verfahren zur herstellung von somatostatinanaloga und zwischenprodukten hierfuer
ATA859578A (de) Verfahren zur herstellung von lokalanoesthetisch wirksamen kombinationspraeparaten
DD137095A5 (de) Verfahren zur herstellung von leichten olefinen und einkernigen aromaten
LU80425A1 (de) Verfahren zur kontinuierlichen herstellung von molkeprodukten
LU80245A1 (de) Verfahren zur herstellung von diphenylmethan-mono-und-di-carbamaten und polymethylen-polyphenylcarbamaten
LU79363A1 (de) Verfahren zur herstellung von diazepinderivaten
DD134061A5 (de) Verfahren und werkzeug zur herstellung von rohren
AT353968B (de) Verfahren zur herstellung von (14-14c)- daunorubicin und(14-14c)-doxorubicin
AT366032B (de) Verfahren zur herstellung von moranolin und n-methylmoranolin
DD134871A5 (de) Verfahren zur herstellung von pyrrolochinoxalinonen und pyrrolobenzdiazepinonen
AT354422B (de) Verfahren zur herstellung von m-halogenmethyl- diphenylaethern
DD133661A1 (de) Verfahren zur herstellung von aethern und/oder aetheralkoholen
DD135823A5 (de) Verfahren zur herstellung von monochlorpinakolin
LU78484A1 (de) Verfahren zur herstellung von benzoxazolyl-phenyl-stilbenen
AT359081B (de) Verfahren zur kontinuierlichen herstellung von nitroguanidin
DD139255A5 (de) Verfahren zur herstellung von(omega-aminoalkoxy)-bibenzylen und ihrer saeureadditionssalze
AT357280B (de) Verfahren zur herstellung von 17alpha- -alkinyl-androst-4-enderivaten
ATA602778A (de) Verfahren zur herstellung von gegebenenfalls neuenn-carboxyalkan-aminoalkan-diphosphonsaeuren n-carboxyalkanhonsaeure-azacycloalkan-diphospho - saeuren und n-carboxyalkan-aminoarylalkan -diphosphonsaeuren
DD136739A5 (de) Verfahren zur herstellung von somatostatinanaloga und zwischenprodukten hierfuer
DD137709A5 (de) Verfahren zur herstellung von thiophenolen
DD132430A1 (de) Verfahren zur herstellung von halbestern und halbamiden substituierter malonsaeuren
AT360757B (de) Verfahren zur kontinuierlichen herstellung von aethylenpolymerisaten
AT348680B (de) Verfahren zur herstellung von arzneipraeparaten
ATA405677A (de) Verfahren zur herstellung von neuen bufadienolid- und bufatrienolidaethern
DD127812A1 (de) Verfahren zur herstellung von 2-mercapto und 2-alkylmercaptothiazolen